If you are an Existing User, please enter your Username & Password below

Forgot Password?

Are you a New User? Click here to enrol

close

Click here to visit old website
Co-Sponsors
SOURCE OF INFORMATION

SOURCE OF INFORMATION : SECURITIES AND EXCHANGE BOARD OF INDIA WEBSITE – PRESS RELEASES/ CHAIRMAN’S AND MEMBER’S ORDERS / AO ORDERS/ SAT ORDERS/ NEWSPAPER ADS
UPDATED TILL : 03-JUL-2025

NAMES IN BROWN COLOUR
Names of entities/persons in brown colour denote that the regulatory order is not against them but their names have been mentioned only for association purposes.

COMPANIES: DIRECTED PROMOTERS OF ASTRAZENECA PHARMA INDIA LTD. TO FINALLY PURCHASE SHARES FROM PUBLIC SHAREHOLDERS IN DELISTING OFFER ONLY AFTER SEEKING APPROVAL OF BSE AND NSE

S.No. ENTITY PERSONS REGULATORY CHARGES REGULATORY ACTION(S) / DATE OF ORDER FURTHER DEVELOPMENTS
1
History of entity/person ASTRAZENECA PHARMA INDIA LTD.  
  MADE OFFER FOR SALE OF SHARES TO SUBSEQUENTLY GET THE SHARES OF ASTRAZENECA PHARMA INDIA LTD.DELISTED   DIRECTED BSE AND NSE TO CLOSELY MONITOR ENTIRE DELISTING PROCESS OF ASTRAZENECA PHARMA INDIA LTD. AND ALLOW DELISTING OF SHARES ONLY AFTER SATISFYING THEMSELVES

DIRECTED BSE AND NSE TO PROMPTLY REPORT ANY ABERRATIONS NOTICED IN DELISTING PROCESS OF ASTRAZENECA PHARMA INDIA LTD.

DIRECTED PROMOTERS OF ASTRAZENECA PHARMA INDIA LTD. TO FINALLY PURCHASE SHARES FROM PUBLIC SHAREHOLDERS IN DELISTING OFFER ONLY AFTER SEEKING APPROVAL OF BSE AND NSE

24-JUN-2014 		SAT: SAT VIDE ITS ORDER DATED 11/09/2015 ACCEPTED THAT RESPONDENT NOS.2 AND 5 SHALL NOT PROCEED WITH THE DELISTING OF EQUITY SHARES OF RESPONDENT NO.2 COMPANY (ASTRAZENECA PHARMA LTD.) TILL COMPLETION OF INVESTIGATION AND PASSING ORDER BY SEBI ON MERITS. DIRECTED SEBI TO COMPLETE INVESTIGATION WITHIN A PERIOD OF SIX MONTHS FROM THE DATE OF THIS ORDER AND PASS APPROPRIATE ORDER ON MERTIS AFTER HEARING THE PARTIES INCLUDING THE APPELLANTS AS EXPEDITIOUSLY AS POSSIBLE. IF THE PASSED BY SEBI IS ADVERSE TO THE APPELLANTS, THEN THE ABOVE STATEMENT MADE BY THE COUNSEL FOR RESPONDENT NOS.2 AND 5 SHALL CONTINUE TILL THE ORDER OF SEBI IS COMMUNICATED TO THE APPELLANS AND FOR A FURTHER PERIOD OF FOUR WEEKS. NO COSTS

SAT: SAT VIDE ITS ORDER DATED 19/01/2017 ALLOWED MISC.APPLICATION TO BE WITHDRAWN. NO COSTS  
The regulatory charges/regulatory actions may be fully or partly applicable to the entities/persons mentioned in the second column.

This website is not comprehensive and is being updated on a regular basis. Users are requested to carefully look at the formats and the information about the coverage period that appears on search results pages.

DISCLAIMER BY NSE

NSE is the co-sponsor of this website and supportive of the initiative taken for protection of interest of investors by Praxis Consulting & Information Services Pvt.Ltd. (PRAXIS), the creator of this website. However, NSE bear no responsibility for the views/information that is available on this website and as responsibility of the contents of this website solely rests with PRAXIS. NSE shall not be responsible for, and expressly disclaims all liability for, damages of any kind arising out of use, reference to or reliance on any information available on this website. Investors/visitors of this website are also advised to read through the other general disclaimer(s) and terms and conditions available on this website before using the website.

Site designed and maintained by watchoutinvestors.com
© PRIME DATABASE GROUP 2004-2025
No part of this site may be reproduced without the explicit permission of the owners.

top